Prime Medicine, Inc. PRME
2.90
(0.17)
(5.54%)
as of 25 Sep
- Market cap
- $609.4M
- P/E
- 0.0×
Follow PRME
| Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|
P/E ratio |
— | 0.00 | — | — | — | 0.00 | 0.00 |
P/S ratio |
— | 0.00 | — | — | — | 0.00 | 111.44 |
P/FCF ratio |
— | 0.00 | — | — | — | 0.00 | 0.00 |
P/Operating CF |
— | (11.35) | — | — | — | 21.32 | (13.86) |
P/B ratio |
— | 0.00 | — | — | — | 2.26 | 4.27 |
Price to Tangible BV |
— | 0.00 | — | — | — | 2.26 | 4.27 |
EV/Sales |
— | 0.00 | — | — | — | 0.00 | 73.08 |
EV/EBITDA |
— | 0.00 | — | — | — | 0.00 | 0.00 |
EV/Operating CF |
— | (1.71) | — | — | — | (1.27) | (2.08) |
EV/FCF |
— | (1.55) | — | — | — | (1.20) | (2.03) |
Quick Ratio |
— | 2.74 | 4.65 | 11.00 | 2.16 | 5.02 | 4.74 |
Current Ratio |
— | 2.75 | 4.67 | 11.10 | 2.53 | 5.58 | 4.84 |
Net Debt/EBITDA |
0.00 | 59.99 | 3.24 | 2.57 | 0.60 | 0.95 | 0.88 |
Debt/Assets |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
Operating CF/Net income |
0.48 | 1.10 | 0.19 | 0.93 | 0.83 | 0.63 | 0.81 |
Capex/Depreciation |
— | (14.86) | (3.23) | (8.15) | (7.01) | (2.40) | (0.84) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 0.00% | 0.00% | 239.27% | (177.48%) | (88.19%) | (136.88%) | (146.81%) | |
| 0.00% | 0.00% | (121.99%) | (42.89%) | (71.51%) | (79.73%) | (62.83%) | |
ROIC |
— | 0.00% | 0.00% | (325.92%) | (1,122.17%) | 0.00% | 0.00% |
Return on Tangible Assets |
0.00% | (14.63%) | (84.64%) | (49.15%) | (181.42%) | (98.77%) | (122.34%) |
Average Days of Receivables |
— | 0.00 | — | — | — | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 57.20% | 0.00% | 0.00% | 0.00% | 5,205.80% | 3,467.96% |
Selling, General and Administrative Expense of Revenue |
0.00% | 60.69% | 0.00% | 0.00% | 0.00% | 1,681.56% | 1,130.09% |
Intangible Assets out of Total Assets |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | 7.50% | 0.00% | 0.00% | 0.00% | 873.89% | 631.87% |
Graham Net Nets |
— | 0.31 | — | — | — | 0.20 | (0.08) |
Graham Number |
— | 0.00 | — | — | — | 0.00 | 0.00 |
Earnings Yield |
— | (33.31%) | — | — | — | (56.51%) | (39.29%) |
Free Cash Flow Yield |
— | (36.87%) | — | — | — | (37.58%) | (32.37%) |
Revenue per Share |
0.00 | 1.97 | 0.00 | 0.00 | 0.00 | 0.03 | 0.03 |
Operating CF per Share |
(0.01) | (2.10) | (2.63) | (3.89) | (1.82) | (1.04) | (1.09) |
Capex per Share |
0.00 | (0.24) | (0.32) | (0.47) | (0.10) | (0.06) | (0.03) |
Free Cash Flow per Share |
(0.01) | (2.34) | (2.95) | (4.36) | (1.91) | (1.10) | (1.12) |
Cash per Share |
0.00 | 20.20 | 20.78 | 8.67 | 1.34 | 1.61 | 1.19 |
Shareholders Equity per Share |
0.00 | 0.00 | 18.47 | 9.33 | 1.46 | 1.29 | 0.81 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 0.00 | 18.47 | 9.33 | 1.46 | 1.29 | 0.81 |
Free Cash Flow |
(1.33) | (6.18) | (38.23) | (147.92) | (174.14) | (130.16) | (167.09) |
Working Capital |
— | 33.96 | 212.60 | 269.90 | 86.55 | 173.93 | 143.85 |
Capital Expenditures |
— | (0.64) | (4.15) | (16.09) | (8.72) | (7.29) | (4.53) |
Net Current Asset Value |
— | 53.40 | 208.28 | 252.57 | 82.20 | 67.53 | (40.57) |
EV/EBIT |
— | 0.00 | — | — | — | 0.00 | 0.00 |
Capex to Sales |
— | 0.12 | 0.00 | 0.00 | 0.00 | 2.45 | 0.98 |
Net Profit Margin |
0.00% | (97.02%) | 0.00% | 0.00% | 0.00% | (6,566.61%) | (4,342.44%) |
Price to Operating Income |
— | 0.00 | — | — | — | 0.00 | 0.00 |
| Other line items | |||||||
Depreciation/Fixed assets |
— | 0.07 | 0.26 | 0.10 | 0.05 | 0.12 | 0.26 |
Cash ROIC |
0.00% | (11.51%) | (7.66%) | (24.72%) | (73.83%) | (42.86%) | (61.34%) |
Accounts Receivable Turnover |
— | 0.00 | — | — | — | 0.00 | 0.00 |
Accounts Payable Turnover |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | 0.00 | 0.00 | — | — | — |
Average Payables |
— | — | 0.84 | 2.88 | 11.93 | 15.44 | 10.12 |
Average Assets |
— | — | 150.93 | 331.09 | 277.08 | 245.68 | 320.12 |
Average Common Equity |
— | — | (76.95) | 80.02 | 224.67 | 143.11 | 137.01 |
Columns are period end dates